APLT Valuation

Applied Therapeutics Inc

Add to Watchlist

Advanced Chart

0.493

-0.019(-3.716%)1D

Overview
Forecast
Valuation
Earnings

APLT Relative Valuation

APLT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, APLT is overvalued; if below, it's undervalued.

Historical Valuation

Applied Therapeutics Inc (APLT) is now in the Fair zone, suggesting that its current forward PS ratio of 283.82 is considered Fairly compared with the five-year average of -3.32. The fair price of Applied Therapeutics Inc (APLT) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：0.49

Fair

-0.81

Trailing

Forward

-0.00

EV/EBITDA

Applied Therapeutics Inc. (APLT) has a current EV/EBITDA of -0.00. The 5-year average EV/EBITDA is -2.48. The thresholds are as follows: Strongly Undervalued below -10.42, Undervalued between -10.42 and -6.45, Fairly Valued between 1.49 and -6.45, Overvalued between 1.49 and 5.46, and Strongly Overvalued above 5.46. The current Forward EV/EBITDA of -0.00 falls within the Historic Trend Line -Fairly Valued range.

-0.44

EV/EBIT

Applied Therapeutics Inc. (APLT) has a current EV/EBIT of -0.44. The 5-year average EV/EBIT is -2.10. The thresholds are as follows: Strongly Undervalued below -7.89, Undervalued between -7.89 and -5.00, Fairly Valued between 0.79 and -5.00, Overvalued between 0.79 and 3.69, and Strongly Overvalued above 3.69. The current Forward EV/EBIT of -0.44 falls within the Historic Trend Line -Fairly Valued range.

283.82

Applied Therapeutics Inc. (APLT) has a current PS of 283.82. The 5-year average PS is 84.26. The thresholds are as follows: Strongly Undervalued below -416.69, Undervalued between -416.69 and -166.22, Fairly Valued between 334.74 and -166.22, Overvalued between 334.74 and 585.21, and Strongly Overvalued above 585.21. The current Forward PS of 283.82 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Applied Therapeutics Inc. (APLT) has a current P/OCF of 0.00. The 5-year average P/OCF is -2.10. The thresholds are as follows: Strongly Undervalued below -9.68, Undervalued between -9.68 and -5.89, Fairly Valued between 1.69 and -5.89, Overvalued between 1.69 and 5.48, and Strongly Overvalued above 5.48. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Applied Therapeutics Inc. (APLT) has a current P/FCF of 0.00. The 5-year average P/FCF is -3.16. The thresholds are as follows: Strongly Undervalued below -10.88, Undervalued between -10.88 and -7.02, Fairly Valued between 0.71 and -7.02, Overvalued between 0.71 and 4.57, and Strongly Overvalued above 4.57. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Applied Therapeutics Inc (APLT) has a current Price-to-Book (P/B) ratio of 4.01. Compared to its 3-year average P/B ratio of 3.57 , the current P/B ratio is approximately 12.34% higher. Relative to its 5-year average P/B ratio of 3.49, the current P/B ratio is about 14.81% higher. Applied Therapeutics Inc (APLT) has a Forward Free Cash Flow (FCF) yield of approximately -129.34%. Compared to its 3-year average FCF yield of -90.72%, the current FCF yield is approximately 42.58% lower. Relative to its 5-year average FCF yield of -82.90% , the current FCF yield is about 56.03% lower.

4.01

P/B

Median3y

3.57

Median5y

3.49

-129.34

FCF Yield

Median3y

-90.72

Median5y

-82.90

Competitors Valuation Multiple

The average P/S ratio for APLT's competitors is 49.37, providing a benchmark for relative valuation. Applied Therapeutics Inc Corp (APLT) exhibits a P/S ratio of 283.82, which is 474.94% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

APLT.O

Applied Therapeutics Inc

Repare Therapeutics Inc

Performance Decomposition

Market capitalization of APLT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of APLT in the past 1 year is driven by Unknown.